Zimmer Biomet
977 hedge funds and large institutions have $24.3B invested in Zimmer Biomet in 2022 Q1 according to their latest regulatory filings, with 104 funds opening new positions, 270 increasing their positions, 588 reducing their positions, and 116 closing their positions.
102% more call options, than puts
Call options by funds: $184M | Put options by funds: $91.2M
86% more funds holding in top 10
Funds holding in top 10: 7 → 13 (+6)
3% more capital invested
Capital invested by funds: $23.7B → $24.3B (+$630M)
0.8% less ownership
Funds ownership: 91.99% → 91.19% (-0.8%)
2% less funds holding
Funds holding: 998 → 977 (-21)
10% less first-time investments, than exits
New positions opened: 104 | Existing positions closed: 116
54% less repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 588
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$375M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$281M |
| 3 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
+$186M |
| 4 |
Neuberger Berman Group
New York
|
+$174M |
| 5 |
JP Morgan Chase
New York
|
+$118M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$317M |
| 2 |
BlackRock
New York
|
-$157M |
| 3 |
Amundi
Paris,
France
|
-$154M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$148M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$115M |
ZBH Hedge Fund Activity: Q1 2022 in Review
977 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2022, worth a combined $24.3B — up 2.7% from $23.7B a quarter earlier.
Sellers outnumbered buyers: 116 funds closed out of ZBH and 104 opened new positions — a net loss of 12 holders — while 588 trimmed existing stakes and 270 added.
The largest buyer was Vanguard Group, adding an estimated $375M. The largest seller was Viking Global Investors, exiting entirely with an estimated $317M sold.
- 977 institutional investors held Zimmer Biomet (ZBH) as of Q1 2022, down from 998 in Q4 2021.
- Funds reported $24.3B of Zimmer Biomet stock for Q1 2022, up 2.7% quarter-over-quarter.
- 104 funds opened new Zimmer Biomet positions in Q1 2022 and 116 closed out, a net change of -12 holders.
- The largest Zimmer Biomet buyer in Q1 2022 was Vanguard Group, an estimated $375M added.
- The largest Zimmer Biomet seller in Q1 2022 was Viking Global Investors, an estimated $317M sold.
Based on aggregated 13F filings for Q1 2022.